Skip to main content

Dr. Alexandre Bazinet, MD

Hematology (Hematology (Internal Medicine) Physician)

  • Medicare participating

At a glance

Years since graduation
12
In the NPI registry since
2021
Medicare patients seen, 2024
98

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2014Medical school: Mcgill University, Faculty of Medicine
  • 2021Registered with an NPI (national billing number; not a license date)

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology (Internal Medicine) Physician primary
    TX license 47986

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology per capita by county →

Where they work

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
98
Services billed
601
Patients’ average age
70
Most frequent Medicare services, 2023
ServiceTimesPatients
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes25831
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes2828
Hospital discharge day management, more than 30 minutes1616

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Valacyclovir (valacyclovir hcl)
Other prescribers in Houston, TX
25
Venclexta (venetoclax)19
Levofloxacin
Other prescribers in Houston, TX
14

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 4 companies reported 4 payments worth $300 in total to this clinician.

By company
Syndax Pharmaceuticals, Inc.$147
Sumitomo Pharma America, Inc.$96.83
Lilly USA, LLC$29.05
Celgene Corporation$26.58
By type
Food and Beverage$300

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Texas →

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $3,600 in research payments for these studies, mostly to the institutions running them.

  • Study name not reported
    Adaptive Biotechnologies Corporation

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Hematology clinicians in Houston

Sources

NPI registry (CMS NPPES, November 2026; record last updated July 19, 2023), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1669045514. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.